Area of research
Genetics · Oncology
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Cells and Metastasis, Immune cells in cancer, and MicroRNA in disease regulation.
GNE-317 Reverses MSN-Mediated Proneural-to-Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR.
RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway.
Cyst fluid ctDNA as a biomarker for genetic profiling and treatment monitoring in cystic brain metastases.
Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p.
Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance
Gene Set (<i>ARL4C, MSN, TNFAIP6</i>) for Prognosis of Glioma
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression
STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells
Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention